Influence of Experimental Diabetes on the Microcirculation of Injured Peripheral Nerve
Functional and Morphological Aspects
- From the Department of Clinical Neurosciences and the Neuroscience Research Group, University of Calgary, Calgary, Alberta, Canada
Abstract
Regeneration of diabetic axons has delays in onset, rate, and maturation. It is possible that microangiopathy of vasa nervorum, the vascular supply of the peripheral nerve, may render an unfavorable local environment for nerve regeneration. We examined local nerve blood flow proximal and distal to sciatic nerve transection in rats with long-term (8 month) experimental streptozotocin diabetes using laser Doppler flowmetry and microelectrode hydrogen clearance polarography. We then correlated these findings, using in vivo perfusion of an India ink preparation, by outlining the lumens of microvessels from unfixed nerve sections. There were no differences in baseline nerve blood flow between diabetic and nondiabetic uninjured nerves, and vessel number, density, and area were unaltered. After transection, there were greater rises in blood flow in proximal stumps of nondiabetic nerves than in diabetic animals associated with a higher number, density, and caliber of epineurial vessels. Hyperemia also developed in distal stumps of nondiabetic nerves but did not develop in diabetic nerves. In these stumps, diabetic rats had reduced vessel numbers and smaller mean endoneurial vessel areas. Failed or delayed upregulation of nerve blood flow after peripheral nerve injury in diabetes may create a relatively ischemic regenerative microenvironment.
Footnotes
-
Address correspondence and reprint requests to Dr. D.W. Zochodne, University of Calgary, Department of Clinical Neurosciences, Room 182A, 3330 Hospital Dr. N.W., Calgary, Alberta, Canada T2N 4N1 41. E-mail: dzochodn{at}ucalgary.ca.
Received for publication 23 July 2001 and accepted in revised form 19 March 2002.
ANOVA, analysis of variance; CGRP, calcitonin gene-related peptide; HC, hydrogen clearance; LDF, laser Doppler flowmetry; MAP, mean arterial pressure; MR, microvascular resistance; NO, nitric oxide; RBC, red blood cell; STZ, streptozotocin; VEGF, vascular endothelial growth factor; VIP, vasoactive intestinal peptide.
- DIABETES











